Toxicology and antidotes
The pharmacological principles behind poisoning care: toxidromes and the receptors that produce them, toxicokinetics in overdose, decontamination and enhanced elimination and why they work only for some drugs, and the mechanism of each major antidote. Doses and thresholds are left to the Australian Medicines Handbook, Poisons Information Centres and local guidelines.
By the end of this page you should be able to
- Describe the main toxidromes and explain each feature from the receptor or channel involved.
- Explain how toxicokinetics change in overdose, including saturable metabolism and prolonged absorption.
- Explain the principles of activated charcoal, urinary alkalinisation and haemodialysis, and the drug properties that make each useful.
- Describe the mechanisms of toxicity of paracetamol, salicylate and toxic alcohols, and how their antidotes or treatments work.
- Describe the mechanism of action of the major antidotes and their limitations.
Toxidromes
A toxidrome is a cluster of signs produced by a shared mechanism. Recognising one narrows the cause and points to treatment even before the drug is known.
- Anticholinergic (muscarinic block): tachycardia, hyperthermia, dry flushed skin, mydriasis, urinary retention, absent bowel sounds, agitated delirium. Antihistamines, tricyclics, some antipsychotics, Datura.
- Sympathomimetic (more catecholamine at adrenergic receptors): tachycardia, hypertension, hyperthermia, mydriasis, agitation, but sweating. Amphetamines, cocaine, MDMA.
- Cholinergic (acetylcholinesterase inhibition): bronchorrhoea, bradycardia, miosis, salivation, vomiting, diarrhoea, fasciculations then weakness. Organophosphates and carbamates.
- Opioid (mu agonism): reduced consciousness, respiratory depression, miosis.
- Sedative-hypnotic (GABA-A enhancement): sedation and ataxia, usually with preserved vital signs when taken alone; dangerous with alcohol and opioids.
- Serotonin toxicity (excess 5-HT2A stimulation): clonus (inducible, ocular, spontaneous), hyperreflexia, agitation, sweating, tremor, hyperthermia; rapid onset after a new or combined serotonergic drug.
- Sodium channel blockade (tricyclics, some antiarrhythmics, local anaesthetics): wide QRS, ventricular arrhythmias, hypotension, seizures.
Toxicokinetics
- Absorption may be prolonged: modified-release preparations, drugs that slow the gut (anticholinergics, opioids) and tablet masses can produce late peaks, so a single early level can mislead.
- Saturation of metabolism turns first-order kinetics into zero-order: elimination becomes a fixed amount per hour, and small further intake raises levels disproportionately (salicylate, phenytoin, ethanol).
- Protein binding sites saturate, raising the free fraction.
- Normal minor pathways can become major: in paracetamol overdose the sulfation and glucuronidation routes saturate, so more drug goes to the toxic pathway.
- Volume of distribution determines whether a drug is reachable by dialysis: a drug largely in tissues is not in the blood to be removed.
Decontamination and enhanced elimination
- Activated charcoal has a vast surface area that adsorbs many drugs in the gut, preventing absorption. It does not bind ions or small polar molecules (lithium, iron, potassium, alcohols), and should not be given to a patient who cannot protect the airway. Repeated doses can also pull drug back from the blood into the gut lumen ("gut dialysis") and interrupt enterohepatic circulation for some drugs (carbamazepine, phenobarbital, theophylline, dapsone, quinine).
- Urinary alkalinisation: salicylate is a weak acid; in alkaline urine more of it is ionised and cannot be reabsorbed (ion trapping), increasing excretion. Raising blood pH also keeps salicylate out of the brain.
- Haemodialysis removes drugs that are small, water soluble, have a small volume of distribution, low protein binding and low endogenous clearance: lithium, toxic alcohols and their metabolites, salicylate, metformin, valproate and theophylline at high levels. It also corrects acidosis and electrolyte disorders.
Mechanisms of three important poisonings
- Paracetamol: normally conjugated by glucuronidation and sulfation; a small fraction is oxidised by CYP2E1 to NAPQI, which glutathione detoxifies. In overdose, conjugation saturates, glutathione is used up, and NAPQI binds hepatocyte proteins, causing zone 3 necrosis. Acetylcysteine supplies cysteine to rebuild glutathione, can conjugate NAPQI directly and has antioxidant effects; it is most effective early, and need is judged against a treatment nomogram from a timed level after a single acute ingestion.
- Salicylate: stimulates the respiratory centre (early respiratory alkalosis), uncouples oxidative phosphorylation (heat, lactate, a high anion gap metabolic acidosis) and impairs glucose metabolism; acidaemia shifts more un-ionised salicylate into the brain. A patient compensating by hyperventilation may deteriorate badly if intubated and ventilated at a normal rate.
- Toxic alcohols: methanol and ethylene glycol are not very toxic themselves; alcohol dehydrogenase converts them to toxic acids (formic acid, which injures the retina and basal ganglia; glycolic and oxalic acids, which cause renal injury with calcium oxalate crystals and hypocalcaemia). Early, the parent alcohol raises the osmolar gap; later, the acids raise the anion gap. Fomepizole (or ethanol, a competing substrate) blocks alcohol dehydrogenase so the parent compound is excreted or dialysed unchanged.
Antidotes and how they work
- Competitive receptor antagonists: naloxone (opioid; shorter acting than many opioids, so resedation occurs; precipitates withdrawal in dependence) and flumazenil (benzodiazepine site of GABA-A; rarely used because it can provoke seizures in dependence or co-ingested proconvulsants).
- Physiological opposition: atropine for muscarinic excess; sodium bicarbonate for sodium channel blockade (sodium load and alkalinisation); calcium, high-dose insulin and vasopressors for calcium channel blockers; glucagon for beta blockers; octreotide for sulfonylurea-induced insulin release; cyproheptadine (a 5-HT2A antagonist) in serotonin toxicity alongside benzodiazepines and cooling.
- Binding or chelating: digoxin-specific antibody fragments bind digoxin and are renally cleared; desferrioxamine chelates iron; hydroxocobalamin binds cyanide to form cyanocobalamin (it colours skin and urine red and interferes with some laboratory tests); antivenoms neutralise circulating venom but cannot reverse established injury.
- Restoring a pathway: acetylcysteine (glutathione); pyridoxine in isoniazid poisoning (isoniazid depletes pyridoxal phosphate, the cofactor for GABA synthesis, causing refractory seizures); methylthioninium chloride (methylene blue) in methaemoglobinaemia, reduced by NADPH-dependent methaemoglobin reductase to a form that converts methaemoglobin back to haemoglobin; it fails, and can cause haemolysis, in G6PD deficiency, and it inhibits MAO (serotonin toxicity risk).
- Enzyme blockade: fomepizole for toxic alcohols.
- Other: lipid emulsion for local anaesthetic systemic toxicity (a "lipid sink" drawing lipophilic drug out of tissues, plus a direct metabolic effect on the heart); oxygen for carbon monoxide.
- Every antidote has its own adverse effects and duration; the patient is monitored for as long as the poison acts, not just the antidote. Doses, thresholds and timing come from the Australian Medicines Handbook, Poisons Information Centres (13 11 26) and local toxicology guidelines.
Making the answer flow
- For a poison: mechanism of toxicity, clinical features explained from it, investigations, then treatment from supportive care to decontamination, elimination and antidote.
- For an antidote: classify how it works (antagonist, physiological opposition, binder, pathway restorer, enzyme blocker), then its limits.
- For enhanced elimination, link the method to the drug property: small Vd for dialysis, weak acid for alkalinisation, enterohepatic circulation for repeat charcoal.
Where marks are lost
- Giving charcoal for lithium, iron or alcohols, or to a patient who cannot protect the airway.
- Forgetting that naloxone wears off before many opioids.
- Calling serotonin toxicity and anticholinergic toxicity the same; sweating and clonus separate them.
- Assuming a normal anion gap early excludes toxic alcohol ingestion.
- Using methylene blue in G6PD deficiency.
- Intubating a salicylate-poisoned patient without matching their high minute ventilation.
Where this meets intensive care
- Acetylcysteine replenishes glutathione to detoxify the paracetamol metabolite NAPQI; it is most effective early but still helps in established liver injury.
- Lipid emulsion acts as a lipid sink for highly lipophilic drugs and may also provide fatty acid fuel to the myocardium.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Distinguish the anticholinergic and sympathomimetic toxidromes.
Show answer
- Shared: tachycardia, hypertension, hyperthermia, mydriasis, agitation.
- Anticholinergic: dry, flushed skin; urinary retention; absent bowel sounds; delirium with picking; muscarinic block.
- Sympathomimetic: sweating (sympathetic cholinergic glands still work), normal or active bowel sounds; adrenergic excess.
- 2.
Explain the mechanism of paracetamol hepatotoxicity and the action of acetylcysteine.
Show answer
- Normal: glucuronidation and sulfation; small fraction to NAPQI via CYP2E1, detoxified by glutathione.
- Overdose: conjugation saturates; glutathione depleted; NAPQI binds cellular proteins: zone 3 necrosis.
- Acetylcysteine: cysteine donor for glutathione synthesis, direct NAPQI conjugation, antioxidant and microcirculatory effects; most effective early.
- Risk assessed with a timed level against a nomogram after a single acute ingestion.
- 3.
Describe the acid-base disturbance in salicylate poisoning.
Show answer
- Early respiratory alkalosis from direct respiratory centre stimulation.
- Then high anion gap metabolic acidosis: uncoupled oxidative phosphorylation, lactate, ketones, salicylate itself.
- Acidaemia increases the un-ionised fraction, which enters the CNS: worsening toxicity.
- Treatment aims: alkalinisation, glucose, dialysis in severe cases; ventilation must match the patient's own if intubated.
- 4.
What properties make a drug removable by haemodialysis?
Show answer
- Low molecular weight; water soluble.
- Small volume of distribution (mostly in blood and ECF).
- Low protein binding.
- Low endogenous clearance, so dialysis adds meaningfully.
- Examples: lithium, toxic alcohols, salicylate, metformin, theophylline, valproate (when binding saturates).
- 5.
How does fomepizole work in methanol poisoning?
Show answer
- Competitive inhibitor of alcohol dehydrogenase.
- Prevents conversion of methanol to formaldehyde and formic acid.
- Parent methanol is excreted slowly or removed by dialysis; folate supports formate metabolism.
- Ethanol works the same way as a preferred substrate but is harder to manage.
- 6.
How does activated charcoal work, and when is it not useful?
Show answer
- Adsorbs drug onto a very large porous surface through weak intermolecular forces, preventing absorption.
- Most useful soon after ingestion of an adsorbable, serious toxin.
- Does not bind metals and ions (lithium, iron, potassium), alcohols, acids or alkalis; not for hydrocarbons.
- Contraindicated with an unprotected airway or ileus; aspiration is the main risk.
- 7.
How does methylene blue treat methaemoglobinaemia, and when might it fail?
Show answer
- Methaemoglobin has ferric iron and cannot carry oxygen; left-shifts remaining haemoglobin.
- Methylene blue is reduced by NADPH-methaemoglobin reductase to leucomethylene blue, which reduces ferric to ferrous iron.
- Fails in G6PD deficiency (no NADPH) and may cause haemolysis; also fails with sulfhaemoglobin.
- Inhibits MAO-A: serotonin toxicity with serotonergic drugs.
- 8.
Why does isoniazid overdose cause seizures, and why does pyridoxine help?
Show answer
- Isoniazid metabolites inactivate pyridoxine and inhibit pyridoxine phosphokinase, depleting pyridoxal 5-phosphate.
- Pyridoxal phosphate is the cofactor for glutamic acid decarboxylase, which makes GABA from glutamate.
- Less GABA, more glutamate: seizures resistant to benzodiazepines (which need GABA to act).
- Pyridoxine replaces the cofactor; benzodiazepines then work.
- 9.
How does digoxin toxicity cause hyperkalaemia, and how do antibody fragments work?
Show answer
- Digoxin inhibits Na/K ATPase in all cells; potassium cannot re-enter cells: hyperkalaemia, a marker of severity in acute poisoning.
- Arrhythmias from increased automaticity (calcium overload) and AV block (vagal effect).
- Fab fragments bind digoxin with high affinity, pulling it off the pump; complex renally excreted.
- Potassium falls as pumps recover; serum digoxin assays become unreliable after Fab.
Practise this week
- First Part MCQs: trauma and toxicology
- First Part MCQs: pharmacology
- First Part SAQs, marked part by part
- First Part cross-table vivas
- Viva Examiner: practise answering aloud
Week 24 in the other subjects
- Physiology: Pregnancy, the placenta and the newborn
Not affiliated with the CICM. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.